IL-33 drives airway hyper-responsiveness through IL-13-mediated mast cell: airway smooth muscle crosstalk

por Kaur, D, Gomez, E, Doe, C, Berair, R, Woodman, L, Saunders, R, Hollins, F, Rose, FR, Amrani, Y, May, R, Kearley, J, Humbles, A, Cohen, ES, Brightling, CE
Publicado 2015

Preclinical development of CAT-354, an IL-13 neutralizing antibody, for the treatment of severe uncontrolled asthma

por May, RD, Monk, PD, Cohen, ES, Manuel, D, Dempsey, F, Davis, NHE, Dodd, AJ, Corkill, DJ, Woods, J, Joberty-Candotti, C, Conroy, LA, Koentgen, F, Martin, EC, Wilson, R, Brennan, N, Powell, J, Anderson, IK
Publicado 2012